Akoya Biosciences Spatial Proteomics Platform to be Used in Cancer Immunotherapy Consortium

MT Newswires Live

2024-10-07

Akoya Biosciences, Inc.0.00%盤後

Akoya Biosciences (AKYA) said Monday that its spatial proteomics platforms will be used to analyze tissue samples as part of the Multiomic Analysis of Immunotherapy Features Evidencing Success and Toxicity, or MANIFEST, program.

The initiative, funded by the UK Office of Life Sciences and the Medical Research Council, seeks to enhance cancer immunotherapy research through in-depth multi-omic profiling.

The MANIFEST consortium will analyze tissue samples from cancer patients using Akoya's platforms, starting with 6,000 patients with breast, bladder, kidney and skin cancers.

Price: 3.20, Change: +0.42, Percent Change: +15.04

免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。

熱議股票

no data

沒有相關數據

{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎證券,老虎證券開戶,老虎券商,老虎證券官網,老虎證券app,tigertrade老虎證券,股票,炒股,新加坡股票交易平臺,投資,投資理財","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hant/news/2473347107"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"2473347107\",edition:\"fundamental\",,,undefined,":{"share":"https://ttm.financial/m/news/2473347107?lang=zh_TW&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2024-10-07 23:20","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2473347107","market":"nz","top_or_hot":-1,"title":"Akoya Biosciences Spatial Proteomics Platform to be Used in Cancer Immunotherapy Consortium","media":"MT Newswires Live","content":"<html><body><p> Akoya Biosciences (AKYA) said Monday that its spatial proteomics platforms will be used to analyze tissue samples as part of the Multiomic Analysis of Immunotherapy Features Evidencing Success and Toxicity, or MANIFEST, program.</p><p>The initiative, funded by the UK Office of Life Sciences and the Medical Research Council, seeks to enhance cancer immunotherapy research through in-depth multi-omic profiling.</p><p>The MANIFEST consortium will analyze tissue samples from cancer patients using Akoya's platforms, starting with 6,000 patients with breast, bladder, kidney and skin cancers.</p><p>Price: 3.20, Change: +0.42, Percent Change: +15.04</p></body></html>","source":"mtnewswires_news","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Akoya Biosciences Spatial Proteomics Platform to be Used in Cancer Immunotherapy Consortium</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 12.5px; color: #7E829C; margin: 0;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nAkoya Biosciences Spatial Proteomics Platform to be Used in Cancer Immunotherapy Consortium\n</h2>\n<h4 class=\"meta\">\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1092851196\">\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/3002d84abbd5ace3c99397c7f95b8d4e);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">MT Newswires Live </p>\n<p class=\"h-time smaller\">2024-10-07 23:20</p>\n</div>\n</a>\n</h4>\n</header>\n<article>\n<html><body><p> Akoya Biosciences (AKYA) said Monday that its spatial proteomics platforms will be used to analyze tissue samples as part of the Multiomic Analysis of Immunotherapy Features Evidencing Success and Toxicity, or MANIFEST, program.</p><p>The initiative, funded by the UK Office of Life Sciences and the Medical Research Council, seeks to enhance cancer immunotherapy research through in-depth multi-omic profiling.</p><p>The MANIFEST consortium will analyze tissue samples from cancer patients using Akoya's platforms, starting with 6,000 patients with breast, bladder, kidney and skin cancers.</p><p>Price: 3.20, Change: +0.42, Percent Change: +15.04</p></body></html>\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"BK4121","symbol_name":"生命科學工具和服務","start_time":0,"source_url":"https://www.mtnewswires.com/","article_id":"2473347107","we_media_id":"1092851196","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2473347107","pubTimestamp":1728314428,"columns":[],"sourceInfo":{"source_id":"mtnewswires_news","name":"MT Newswires"},"weMediaInfo":{"media_name":"MT Newswires Live","introduction":"The most recognized names in North America, Europe and Asia rely on MT Newswires to power their applications. Better news, better service, better price.","home_visible":1,"id":"1092851196","head_image":"https://community-static.tradeup.com/news/3002d84abbd5ace3c99397c7f95b8d4e"},"summary":"Akoya Biosciences  said Monday that its spatial proteomics platforms will be used to analyze tissue samples as part of the Multiomic Analysis of Immunotherapy Features Evidencing Success and Toxicity, or MANIFEST, program.The initiative, funded by the UK Office of Life Sciences and the Medical Research Council, seeks to enhance cancer immunotherapy research through in-depth multi-omic profiling.The MANIFEST consortium will analyze tissue samples from cancer patients using Akoya's platforms, starting with 6,000 patients with breast, bladder, kidney and skin cancers.Price: 3.20, Change: +0.42, Percent Change: +15.04","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"BK4121":"生命科学工具和服务","BK4539":"次新股","AKYA":"Akoya Biosciences, Inc."},"translate_title":"Akoya Biosciences空间蛋白质组学平台将用于癌症免疫治疗联盟","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"AKYA":1},"content_text":"Akoya Biosciences (AKYA) said Monday that its spatial proteomics platforms will be used to analyze tissue samples as part of the Multiomic Analysis of Immunotherapy Features Evidencing Success and Toxicity, or MANIFEST, program.The initiative, funded by the UK Office of Life Sciences and the Medical Research Council, seeks to enhance cancer immunotherapy research through in-depth multi-omic profiling.The MANIFEST consortium will analyze tissue samples from cancer patients using Akoya's platforms, starting with 6,000 patients with breast, bladder, kidney and skin cancers.Price: 3.20, Change: +0.42, Percent Change: +15.04","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"0","news_tag":"","news_rank":0,"symbols":[],"gpt_button":1}}}

如果下載按鈕點擊無跳轉，請點擊右上角菜單選擇 “在瀏覽器打開”

立即諮詢
下載APP
掃碼下載APP